| P50 | author | Andrew Schally | Q141147 |
| P2093 | author name string | Plonowski A | |
| | Rekasi Z | |
| | Varga JL | |
| | Csernus B | |
| | Czompoly T | |
| P2860 | cites work | Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers. | Q24652328 |
| | Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 |
| | Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone | Q30454262 |
| | Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate. | Q34393704 |
| | Synthesis and biological evaluation of antagonists of growth hormone-releasing hormone with high and protracted in vivo activities. | Q34846722 |
| | Antagonistic actions of analogs related to growth hormone-releasing hormone (GHRH) on receptors for GHRH and vasoactive intestinal peptide on rat pituitary and pineal cells in vitro | Q35011890 |
| | Molecular cloning of human prostate specific antigen cDNA. | Q35076151 |
| | Human prostate-specific antigen: structural and functional similarity with serine proteases | Q35604260 |
| | A method for evaluation of activity of antagonistic analogs of growth hormone-releasing hormone in a superfusion system | Q36157690 |
| | Protein secretion and secretory processes in male accessory sex glands. | Q37930416 |
| | Prostate-specific antigen expression is regulated by an upstream enhancer | Q38360200 |
| | Detection of Organ-Confined Prostate Cancer Is Increased Through Prostate-Specific Antigen—Based Screening | Q39377765 |
| | Antiangiogenic activity of prostate-specific antigen | Q40924866 |
| | Seminal vesicle-secreted proteins and their reactions during gelation and liquefaction of human semen | Q41015043 |
| | An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter | Q41131631 |
| | Regulation of proliferation and production of prostate-specific antigen in androgen-sensitive prostatic cancer cells, LNCaP, by dihydrotestosterone | Q41378207 |
| | The human prostate gland: a histochemical and immunohistochemical study of neuropeptides, serotonin, dopamine beta-hydroxylase and acetylcholinesterase in autonomic nerves and ganglia | Q44287163 |
| | Prostate-specific Antigen: Its Usefulness in Clinical Medicine | Q45876737 |
| | Prostate-Specific antigen expression by various tumors | Q57943694 |
| | New biological functions of prostate-specific antigen? | Q71692391 |
| | Neuroendocrine peptides in the prostate | Q71710579 |
| | Vasoactive intestinal peptide stimulates prostate-specific antigen secretion by LNCaP prostate cancer cells | Q71712903 |
| | Modulation of cyclic AMP and inositol phosphate production in rat prostatic cultures by VIP/PACAP, ATP, and carbachol: role in prostatic proliferation | Q71969661 |
| | Mitogenic Response of Osteoblast Cells to Prostate-Specific Antigen Suggests an Activation of Latent TGF-β and a Proteolytic Modulation of Cell Adhesion Receptors | Q72078910 |
| | Antagonistic Analogs of Growth Hormone-releasing Hormone: New Potential Antitumor Agents | Q73134073 |
| | Type 1 vasoactive intestinal peptide receptor expression in PC3/AR cells is evidence of prostate epithelial differentiation | Q73317324 |
| | Antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide inhibit tumor proliferation by different mechanisms: evidence from in vitro studies on human prostatic and pancreatic cancers | Q73832188 |
| | Post-therapy serum prostate-specific antigen level and survival in patients with androgen-independent prostate cancer | Q74484238 |
| | Vasoactive intestinal polypeptide: biologic role in health and disease | Q81080404 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 188-199 | |
| P577 | publication date | 2001-08-01 | |
| P1433 | published in | The Prostate | Q7758608 |
| P1476 | title | Regulation of prostate-specific antigen (PSA) gene expression and release in LNCaP prostate cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide | |
| P478 | volume | 48 | |